Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE : revenue, balance sheet and financial ratios

SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE is a French company founded 16 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in COLMAR (68000), this company of category PME shows in 2015 a revenue of 207 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE (SIREN 517571832)
Indicator 2017 2016 2015
Revenue N/C N/C 207 070 €
Net income 263 622 € 810 629 € -891 637 €
EBITDA N/C N/C 1 982 €
Net margin N/C N/C -430.6%

Revenue and income statement

In 2017, SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE generates positive net income of 264 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2017) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

263 622 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 53%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2017) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

53.304%

Financial autonomy (2017) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

52.383%

Solvency indicators evolution
SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE

Sector positioning

Debt ratio
53.3 2017
2015
2016
2017
Q1: 0.0
Med: 6.83
Q3: 49.59
Average +50 pts over 3 years

In 2017, the debt ratio of SOCIETE DE DEVELOPPEMENT ... (53.30) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
52.38% 2017
2015
2016
2017
Q1: 14.21%
Med: 37.04%
Q3: 60.18%
Good +42 pts over 3 years

In 2017, the financial autonomy of SOCIETE DE DEVELOPPEMENT ... (52.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
-1.29 years 2015
2015
Q1: -0.01 years
Med: 0.0 years
Q3: 0.28 years
Excellent

In 2015, the repayment capacity of SOCIETE DE DEVELOPPEMENT ... (-1.29) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 2125.22. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2017) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

2125.225

Liquidity indicators evolution
SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE

Sector positioning

Liquidity ratio
2125.22 2017
2015
2016
2017
Q1: 131.18
Med: 189.43
Q3: 305.54
Excellent +32 pts over 3 years

In 2017, the liquidity ratio of SOCIETE DE DEVELOPPEMENT ... (2125.22) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
452.98x 2015
2015
Q1: 0.0x
Med: 0.0x
Q3: 2.63x
Excellent

In 2015, the interest coverage of SOCIETE DE DEVELOPPEMENT ... (453.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2017) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2017) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2017) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2017) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE

Positioning of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE is estimated at 216 569 € (range 82 427€ - 790 884€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2017
124 transactions
82k€ 216k€ 790k€
216 569 € Range: 82 427€ - 790 884€
NAF 5 all-time

Valuation method used

Net Income Multiple
263 622 € × 0.8x = 216 570 €
Range: 82 428€ - 790 885€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE

What is the revenue of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE ?

The revenue of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE in 2015 is 207 k€.

Is SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE profitable?

Yes, SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE generated a net profit of 264 k€ in 2017.

Where is the headquarters of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE ?

The headquarters of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE is located in COLMAR (68000), in the department Haut-Rhin.

Where to find the tax return of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE ?

The tax return of SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE operate?

SOCIETE DE DEVELOPPEMENT DE LA PHARMACIE FRANCAISE operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.